Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis
This study is currently recruiting participants.
Verified June 2011 by Ore Pharmaceuticals, Inc.
Study NCT01039597   Information provided by Ore Pharmaceuticals, Inc.

First Received on December 23, 2009.   Last Updated on June 7, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mild to Moderate Ulcerative Colitis
Additional conditions recognized in this trial
Colitis
Colitis, Ulcerative
Ulcer
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Pathologic Processes
Interventions listed in this trial
ORE1001
Placebo
Sponsors listed in this trial
Ore Pharmaceuticals, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services